Belhaven Biopharma
Belhaven Biopharma is dedicated to developing innovative, accessible, and effective allergy treatments, with a focus on needle-free, dry powder nasal epinephrine solutions like Nasdepi®. Their mission is to make lifesaving allergy medications more accessible, easier to administer, and environmentally sustainable, aiming to improve emergency care worldwide.
Industries
Nr. of Employees
small (1-50)
Patents
Intranasal composition of pharmaceutical countermeasures for chemical warfare nerve agents and accidental exposure to organophosphate pesticides
US-12102629-B1
View DetailsMedical counter measures including dry powder formulations and associated methods
US-12005185-B2
View DetailsIntranasal composition of pharmaceutical countermeasures for chemical warfare nerve agents and accidental exposure to organophosphate pesticides
US-11433063-B1
View Details
Intranasal composition of pharmaceutical countermeasures for chemical warfare nerve agents and accidental exposure to organophosphate pesticides
US-12102629-B1
View DetailsMedical counter measures including dry powder formulations and associated methods
US-12005185-B2
View DetailsIntranasal composition of pharmaceutical countermeasures for chemical warfare nerve agents and accidental exposure to organophosphate pesticides
US-11433063-B1
View DetailsProducts
Dry powder epinephrine nasal spray (unit-dose nasal powder device)
A needle-free, unit-dose dry powder nasal delivery product under clinical development to provide intranasal epinephrine for treatment of severe allergic reactions and anaphylaxis; designed for rapid absorption, passive operation, heat stability, and extended shelf life.
Dry powder epinephrine nasal spray (unit-dose nasal powder device)
A needle-free, unit-dose dry powder nasal delivery product under clinical development to provide intranasal epinephrine for treatment of severe allergic reactions and anaphylaxis; designed for rapid absorption, passive operation, heat stability, and extended shelf life.
Services
Early-phase clinical study design and execution combined with regulatory planning focused on bioequivalence pathways to accelerate approvals of reformulated drugs.
Development of spray-dried nasal powder formulations and passive unit-dose nasal delivery devices intended for emergency medication administration.
Comparative pharmacokinetic and bioavailability testing in animal models and analytical studies such as nasal deposition assessments and stability evaluations.
Early-phase clinical study design and execution combined with regulatory planning focused on bioequivalence pathways to accelerate approvals of reformulated drugs.
Development of spray-dried nasal powder formulations and passive unit-dose nasal delivery devices intended for emergency medication administration.
Comparative pharmacokinetic and bioavailability testing in animal models and analytical studies such as nasal deposition assessments and stability evaluations.
Expertise Areas
- Dry powder nasal drug delivery
- Formulation development and spray drying
- Pharmacokinetics and bioavailability studies
- Early-phase clinical trial management
Key Technologies
- Spray-dried powder formulation
- Dry powder intranasal delivery
- Intranasal nasal mucosa absorption
- Pharmacokinetic (PK) and bioavailability testing
News & Updates
Discussion on the environmental impact of traditional EpiPens and the sustainable benefits of Nasdepi®, a needle-free nasal spray alternative.
Practical tips for managing allergies and how Nasdepi® offers fast, needle-free relief in emergencies.
Discussion on the environmental impact of traditional EpiPens and the sustainable benefits of Nasdepi®, a needle-free nasal spray alternative.
Practical tips for managing allergies and how Nasdepi® offers fast, needle-free relief in emergencies.